Insider Transactions in Q4 2025 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
24,800
-1.36%
|
$13,664,800
$551.76 P/Share
|
|
Dec 10
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,800
+10.47%
|
$372,000
$15.8 P/Share
|
|
Dec 10
2025
|
Rebecca Taub Director |
SELL
Bona fide gift
|
Direct |
5,455
-1.18%
|
-
|
|
Dec 10
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
18,650
-0.44%
|
$10,276,150
$551.79 P/Share
|
|
Dec 10
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
18,650
+3.74%
|
$279,750
$15.8 P/Share
|
|
Dec 04
2025
|
William John Sibold President and CEO |
SELL
Open market or private sale
|
Direct |
2,400
-1.57%
|
$1,380,000
$575.34 P/Share
|
|
Dec 03
2025
|
William John Sibold President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+24.69%
|
-
|
|
Dec 02
2025
|
Mardi Dier EVP and CFO |
SELL
Open market or private sale
|
Direct |
4,173
-2.21%
|
$2,424,513
$581.45 P/Share
|
|
Dec 02
2025
|
Mardi Dier EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,173
+22.21%
|
$1,047,423
$251.63 P/Share
|
|
Nov 21
2025
|
Carole Huntsman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,958
-1.59%
|
$1,086,690
$555.09 P/Share
|
|
Nov 13
2025
|
Richard S Levy Director |
SELL
Open market or private sale
|
Direct |
8,500
-2.36%
|
$4,437,000
$522.33 P/Share
|
|
Nov 13
2025
|
Richard S Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+13.18%
|
$93,500
$11.91 P/Share
|
|
Nov 05
2025
|
Kenneth Bate Director |
SELL
Open market or private sale
|
Direct |
16,575
-15.93%
|
$8,038,875
$485.61 P/Share
|
|
Nov 05
2025
|
Kenneth Bate Director |
BUY
Exercise of conversion of derivative security
|
Direct |
16,575
+27.12%
|
$3,265,275
$197.76 P/Share
|